EDEN RESEARCH PLC

Director's Dealing • May 8, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2991N

Eden Research plc

08 May 2018

8 May 2018

Eden Research plc

("Eden" or "Company")

Exercise of Options

Director/PDMR Shareholding

Eden Research plc (AIM: EDEN), the AIM listed company that provides breakthrough natural microencapsulation technologies to the global agrochemicals, animal health and consumer products industries, announces it has issued 125,000 ordinary shares of 1 pence each in the Company ("Ordinary Shares") following the exercise of 125,000 options at 10.4 pence per share by the Company's Chief Financial Officer, Alex Abrey, under the Company's share option scheme.

Application has been made for the new Ordinary Shares to be admitted to trading on AIM, which is expected to take place on 14 May 2018.  The new Ordinary Shares will rank, pari passu, with the existing Ordinary Shares in issue.

Following the transaction outlined above Mr Abrey's interest in the share capital of the Company has increased to a total of 1,163,160 Ordinary Shares representing 0.56 per cent. of the Company's issued share capital enlarged pursuant to the exercise of options. 

Total Voting Rights

Following the issue of the new Ordinary Shares, the Company will have 207,189,337 ordinary shares of 1 pence each in issue. No Ordinary Shares are held in treasury. The figure of 207,189,337 may be used by the Company's shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further details of the PDMR dealings set out above.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mr Alex Abrey

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Eden Research plc

b)

LEI

213800ZWTYTVQQSM3J85

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each in the Company ("Ordinary Shares")

GB0001646941

b)

Nature of the transaction

Exercise of Options over Ordinary Shares

c)

Price(s) and volume(s)

Exercise Price(s)	Volume(s)
10.4  pence per share	125,000 Ordinary Shares

d)

Aggregated information

- Aggregated volume

- Price

N/A (single transaction)

e)

Date of the transaction

07/05/2018

f)

Place of the transaction

Outside of a trading venue.

For further information contact:

Eden Research plc	www.edenresearch.com
Sean Smith Alex Abrey	01285 359 555
Shore Capital (Nomad)	020 7408 4090
Stephane Auton / Patrick Castle
Powerscourt (Financial PR)	020 7250 1446
Nick Dibden

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCGUGDUCDGBGII